Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Non Operating Income of -$1.0 million for Q4 2025, down 77.36% sequentially from -$592000.0 in Q3 2025, and up 7.89% YoY from -$973170.7 in Q4 2024.
Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Non Operating Income for 7 years, with the latest figure at -$1.0 million in Q4 2025.
- Quarterly Non Operating Income rose 7.89% year-over-year to -$1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.7 million (down 206.69% YoY) and the FY2025 annual result came in at -$3.7 million, down 206.69% from the prior year.
- Non Operating Income retreated to -$1.0 million in Q4 2025 per ETON's latest filing, from -$592000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $784000.0 in Q4 2023 and troughed at -$1.1 million in Q4 2024.
- A 5-year average of -$269450.0 and a median of -$227500.0 in 2021 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income jumped 622.67% in 2023, then sank 9245.45% in 2025.
- Over 5 years, Non Operating Income stood at -$275000.0 in 2021, then jumped by 45.45% to -$150000.0 in 2022, then surged by 622.67% to $784000.0 in 2023, then tumbled by 245.41% to -$1.1 million in 2024, then increased by 7.89% to -$1.0 million in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered -$1.0 million, -$592000.0, and -$1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.08 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | -592,000.00 |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 784,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Jun 30, 2023 | 676,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Dec 31, 2022 | -150,000.00 |
| Sep 30, 2022 | -150,000.00 |
| Jun 30, 2022 | -218,000.00 |
| Mar 31, 2022 | -243,000.00 |
| Dec 31, 2021 | -275,000.00 |
| Sep 30, 2021 | -247,000.00 |
| Jun 30, 2021 | -237,000.00 |